Firstpostadded this to FirstPostGlaxoSmithKline CCI approves GlaxoSmithKline, Pfizer consumer healthcare joint ventureFirstpost - Press Trust of India New Delhi: The Competition Commission on Friday said it has approved the formation of a joint venture for consumer healthcare products by …
Seeking AlphaInvesting Pfizer Has Limited DownsideSeeking Alpha - Individual Trader Pfizer Inc. (NYSE:PFE) remains a core part of our portfolio for various reasons. The most significant reason is that shares have been consolidating …
Seeking AlphaInvesting Exact Sciences: Fantastic Revenue Growth, But It Operates At A LossSeeking Alpha - Kurt Pollet Exact Sciences Corporation (EXAS) has plenty of revenue growth potential, but the analysts are expecting more earnings losses. Due to its earnings …
Investing.com Indiaadded this to India NewsS&P 500 Medtronic earnings, Revenue beat in Q4investing.com Investing.com - Medtronic (NYSE:MDT) reported fourth quarter earnings that beat analysts' expectations on Thursday and revenue that topped …
PPeak Bggradded this to Biotech InvestingCocaine Tonix up 9% premarket on new pipeline candidateSeeking Alpha - Mamta Mayani Tonix Pharmaceuticals (NASDAQ:TNXP) has in-licensed a Phase 2 asset, TNX-1300 (T172R/G173Q double-mutant cocaine esterase 200 mg, i.v. solution) for …
FlipboardIcon version of the Flipboard logo Lannett Appoints Melissa V. Rewolinski, PhD, To Board Of Directorsyahoo.com - PR Newswire PHILADELPHIA, May 23, 2019 /PRNewswire/ -- Lannett Company, Inc. (LCI) today announced the appointment of Melissa V. Rewolinski, PhD, to its board of …
PPeak Bggradded this to Biotech InvestingInvesting Pfizer Posts Positive Phase 3 Study In Eczema, Catalysts Remain In Second Half Of 2019Seeking Alpha - Terry Chrisomalis Pfizer (PFE) announced that it had achieved positive top-line results for its phase 3 study using abrocitinib to treat patients with atopic …
PPeak Bggradded this to Biotech InvestingBaby Powder J&J loses talc case in NY, ordered to pay $25MSeeking Alpha - Douglas W. House A New York jury has sided with the plaintiff in a court case (one of thousands) brought by a woman who claimed that Johnson & Johnson's (JNJ +0.2%) …
Nicholas Gaudiosiadded this to Convergence Health Clinical Trials Alphabet's Verily partners with pharma companies to improve clinical trialsCNET - by Abrar Al-Heeti Through the partnerships, the life sciences company hopes to implement a more tech-driven approach to research.
Seeking AlphaInvesting Synlogic teams up with Roche in potential combo therapy for solid tumorsSeeking Alpha - Douglas W. House Synlogic (NASDAQ:SYBX) will collaborate with Roche (OTCQX:RHHBY) on clinical studies evaluating the combination of SYNB1891, a STING agonist, and …
The Motley FoolAbbVie Better Buy: AbbVie vs. PfizerThe Motley Fool - George Budwell AbbVie and Pfizer are both undergoing a radical makeover. Which company should investors trust to come out even stronger? Over the last five years, …
Clinical Trials Four of the world’s largest drug companies are teaming with Verily. Here is what they getstatnews.com - Matthew Herper Four of the world’s largest drug companies are teaming with Verily in a bid to improve clinical trials. Here's what they're trying to do. On Tuesday …
UC San Diego Office Bridges Gap Between Discovery, Therapeuticsnbcsandiego.com - Jared Whitlock - SDBJ Staff A department at UC San Diego Health’s Moores Cancer Center is known for putting on a symposium to translate groundbreaking oncology discoveries into …
PPeak Bggradded this to Biotech InvestingEli Lilly Lilly's mirikizumab shows positive effect in mid-stage Crohn's studySeeking Alpha - Douglas W. House New data from a Phase 2 clinical trial, SERENITY, evaluating Eli Lilly's (LLY +0.4%) mirikizumab in patients with moderately to severely active …
PPeak Bggradded this to Biotech InvestingInvesting Pfizer: Added Value For A Defensive Pharma PortfolioSeeking Alpha - Christiana Friedman The terrain in biotech and pharma is getting treacherous, and it may be Big Pharma’s time to shine after, in some cases, decades of consolidation. …
RRobertGoodnightadded this to PINTREST Credit Suisse Credit Suisse Absolutely Is Right to Double Down on Pfizer Stockyahoo.com - James Brumley After upgrading Pfizer (NYSE:PFE) to “Outperform” in January and raising its price target on Pfizer stock to $48 in May, one would think there’s …
FlipboardIcon version of the Flipboard logoNovartis Verily Forms Strategic Alliances with Novartis, Otsuka, Pfizer and Sanofi to Transform Clinical Researchyahoo.com - Business Wire Leading biopharmaceutical organizations join Project Baseline initiative to engage more patients and clinicians in research and speed evidence …
Seeking AlphaMerck Merck KGaA FDA Approval Moves It Towards A Competitive SpaceSeeking Alpha - Terry Chrisomalis Merck KGaA (OTCPK:MKKGY) (OTCPK:MKGAY) and its partner Pfizer (PFE) announced that they had obtained FDA approval for their drug Bavencio to treat …
AxiosClinical Trials Pfizer's blood thinner Fragmin approved for use in children after a single clinical trialAxios - Bob Herman The FDA gave the OK last week for Pfizer's blood thinner Fragmin to be used in children — but Fragmin is not new, it's been on the market for adults …
Seeking AlphaC-suite Leadership New chief commercial officer at Seattle GeneticsSeeking Alpha - Mamta Mayani Seattle Genetics (NASDAQ:SGEN) appoints Robin G. Taylor, M.B.A., Ph.D., as Chief Commercial Officer. Most recently, Dr. Taylor served as Vice …
Seeking AlphaNovartis Alphabet teams with Pfizer, Novartis on clinical trialsSeeking Alpha - Brandy Betz Alphabet's (GOOGL,GOOG) Project Baseline is a data platform from the Verily unit that wants to develop a "well-defined reference" of good …
Seeking AlphaInvesting Pfizer: A 3.5% Yield, But Lyrica's Patent Loss Keeps Me From BuyingSeeking Alpha - Dividend Power As far as big pharma stocks go, Pfizer Inc. (PFE) is one that is usually considered a safe and conservative one to own. In fact, I used to own Pfizer …
Seeking AlphaInvesting Pfizer Nabs Regulatory Approval For Tafamidis, An FDA First Is AchievedSeeking Alpha - Terry Chrisomalis Pfizer (PFE) was able to obtain FDA approval for its drugs by the name of Vyndaqel and Vyndamax (tafamidis) to treat patients with transthyretin …
Eli Lilly Better Buy: Eli Lilly vs. Pfizeryahoo.com - Keith Speights, The Motley Fool If you're looking to add a big pharma stock to your portfolio, Eli Lilly (NYSE: LLY) and Pfizer (NYSE: PFE) are naturally two top candidates. Both big …
FOX Businessadded this to Markets Where Will Pfizer Be in 5 Years?FOX Business - Motley FoolDrug stocks have taken a hit lately as the market has started to worry about political pressures that may come to bear on pricing and affect profits. But stocks of large pharmaceutical companies can often
Patchadded this to New York, NY PatchFortune 500 Fortune 500: These NYC Companies Are Among Nations BiggestPatch - Adam Nichols NEW YORK – The top 500 companies in America – huge businesses that represent two-thirds of the nation's GDP and bring in $13.7 trillion a year in …
CNBCadded this to InvestingMacy's Here are the biggest analyst calls of the day: Macy's, Owens Corning & moreCNBC - Michael Bloom Here are the biggest calls on Wall Street on Thursday: Goldman said the underperformance of the stock leads to a more "balanced" risk/reward. "We …
CNBCadded this to Top NewsSony Stocks making the biggest moves premarket: Walmart, Pfizer, PG&E, Sony, Tesla & moreCNBC - Peter Schacknow Walmart — The retail giant reported adjusted quarterly profit of $1.13 per share, 11 cents a share above Wall Street forecasts. Revenue came in below …
TheStreetadded this to InvestingCredit Suisse Pfizer Gains After Being Named 'Top Pick' by Credit SuisseTheStreet - M. Corey Goldman Colfax strikes a deal to sell its air and gas handling division to private-equity firm KPS Capital Partners for approximately $1.8 billion. Department …
Aamir Khalil Mirzaadded this to #LIKESHumor Pfizer Denies Encouraging Drug Abuse By Packaging Fentanyl With Cooking Spoon, Lightertheonion.com - The Onion NEW YORK—In an effort to address the growing controversy surrounding widespread non-medical use of their products, pharmaceutical giant Pfizer …
